CN114586775B - Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX - Google Patents

Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX Download PDF

Info

Publication number
CN114586775B
CN114586775B CN202210237496.9A CN202210237496A CN114586775B CN 114586775 B CN114586775 B CN 114586775B CN 202210237496 A CN202210237496 A CN 202210237496A CN 114586775 B CN114586775 B CN 114586775B
Authority
CN
China
Prior art keywords
pcmx
polyoxyethylene ether
composition
acid amide
amide polyoxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210237496.9A
Other languages
Chinese (zh)
Other versions
CN114586775A (en
Inventor
郭建华
车婷婷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhaoqing Honghao Biotechnology Co ltd
Original Assignee
Zhaoqing Honghao Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhaoqing Honghao Biotechnology Co ltd filed Critical Zhaoqing Honghao Biotechnology Co ltd
Priority to CN202210237496.9A priority Critical patent/CN114586775B/en
Publication of CN114586775A publication Critical patent/CN114586775A/en
Application granted granted Critical
Publication of CN114586775B publication Critical patent/CN114586775B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a composition beneficial to the stability of a PCMX sterilizing liquid. The composite material consists of the following components in percentage by mass: 3-6% of ricinoleic acid amide polyoxyethylene ether, 15-30% of fatty acid salt and the balance of water; wherein, the ricinoleic acid amide polyoxyethylene ether comprises the following components in percentage by mass: 15-60% of ricinoleic acid amide polyoxyethylene ether with the addition number of the ethylene oxide being 1-5; 30-80% of ricinoleic acid amide polyoxyethylene ether with the addition number of ethylene oxide being 15-20. Also discloses a sterilization liquid containing PCMX. The composition can help the stability of PCMX under lower dosage, reduce the content of double bonds of castor oil in a system, and reduce the problem of discoloration of the sterilizing liquid caused by oxidation of the double bonds of the castor oil.

Description

Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX
Technical Field
The invention belongs to the field of daily chemical disinfection and sterilization, and particularly relates to a composition beneficial to the stability of a PCMX (prestressed concrete cylinder pipe) degerming liquid and the degerming liquid containing the PCMX.
Background
The sterilization products are widely used, wherein the sterilization agent p-chlorom-xylenol (PCMX) has low toxicity and good sterilization and bacteriostasis capability, and is widely used in the sterilization products. PCMX is poorly soluble in water and in organic solvents such as isopropanol and ethanol. The current general technical method is to add castor oil soap and solvents such as terpineol, ethanol or isopropanol into the formulation of the degerming product to form a relatively stable PCMX aqueous solution. However, when the sterilized product is stored for a long time or when the temperature is changed, the stability of the system is challenged, and problems of high-temperature delamination or low-temperature precipitation occur. The prior technical proposal for solving the stability of the PCMX aqueous solution is to add a large amount of non-aqueous solvent, thereby increasing the cost and material consumption of the degerming product.
Disclosure of Invention
Based on this, a first object of the present invention is to provide a composition beneficial for the stability of PCMX antiseptic solutions, which effectively solves the drawbacks of the prior art.
The second object of the present invention is to provide a PCMX-containing antibacterial solution.
In order to achieve the first object, the invention adopts the following technical scheme:
a composition beneficial to the stability of a PCMX antibacterial solution comprises the following components in percentage by mass: 3-6% of ricinoleic acid amide polyoxyethylene ether, 15-30% of fatty acid salt and the balance of water; wherein, the ricinoleic acid amide polyoxyethylene ether comprises the following components in percentage by mass: 15-60% of ricinoleic acid amide polyoxyethylene ether with the addition number of the ethylene oxide being 1-5; 30-80% of ricinoleic acid amide polyoxyethylene ether with the addition number of ethylene oxide being 15-20.
Preferably, the fatty acid salt comprises castor oil soap. Further, the mass percentage of the castor oil soap in the fatty acid salt is 70-100%. The castor oil soap comprises castor oil potassium soap, castor oil sodium soap, castor oil magnesium soap and castor oil monoethanolamine soap, wherein the castor oil potassium soap is preferred.
Preferably, the fatty acid salt further comprises oleate. Further, the mass percentage of the oleate in the fatty acid salt is 0-30%. The oleic acid soap comprises oleic acid potassium soap, oleic acid sodium soap, oleic acid magnesium soap and oleic acid monoethanolamine soap, wherein oleic acid potassium soap is preferred.
Further preferably, the mass ratio of the ricinoleic acid amide polyoxyethylene ether to the fatty acid salt is preferably 1:5.
preferably, the composition is prepared as follows: 1) Uniformly mixing 1/3 part of ricinoleic acid amide polyoxyethylene ether and fatty acid salt; 2) Adding water with the formula amount into the mixture obtained in the step 1), and stirring until the water is completely dissolved; 3) Adding the rest 2/3 parts of ricinoleic acid amide polyoxyethylene ether into the step 2), and uniformly mixing.
In order to achieve the second purpose, the invention adopts the following technical scheme:
the PCMX-containing antibacterial solution comprises PCMX and also comprises the composition, wherein the mass percentage of the composition is 5-18%.
Preferably, the mass ratio of PCMX to the composition is 0.2-0.5:1.
compared with the prior art, the invention has the following advantages:
1, the ricinoleic acid amide polyoxyethylene ether and the fatty acid salt are compounded, and compared with the fatty acid salt single surfactant, the HLB value of the composition is optimized. When the composition is applied to a sterilization liquid containing PCMX, the composition helps to establish a stable PCMX solution system, further helps to reduce the dosage of solvents such as isopropanol, terpineol and the like, improves the green of the product and has good economic value.
2, compared with fatty acid salt, the composition can help the stability of PCMX at a lower dosage, reduce the content of castor oil double bonds in the system, and reduce the problem of discoloration of the sterilizing liquid caused by oxidation of the castor oil double bonds.
The invention is described in detail below for a better understanding and implementation.
Detailed Description
The invention relates to a composition for improving the stability of a sterilization liquid containing PCMX, which comprises the following components in percentage by mass: 3-6% of ricinoleic acid amide polyoxyethylene ether, 15-30% of fatty acid salt and the balance of water; wherein, the ricinoleic acid amide polyoxyethylene ether comprises the following components in percentage by mass: 15-60% of ricinoleic acid amide polyoxyethylene ether with the addition number of the ethylene oxide being 1-5; 30-80% of ricinoleic acid amide polyoxyethylene ether with the addition number of ethylene oxide being 15-20.
Preferably, the fatty acid salt comprises castor oil soap. Further, the mass percentage of the castor oil soap in the fatty acid salt is 70-100%. The castor oil soap comprises castor oil potassium soap, castor oil sodium soap, castor oil magnesium soap, castor oil monoethanolamine soap, preferably castor oil potassium soap.
Preferably, the fatty acid salt further comprises oleate. Further, the mass percentage of the oleate in the fatty acid salt is 0-30%. The oleic acid soap comprises oleic acid potassium soap, oleic acid sodium soap, oleic acid magnesium soap and oleic acid monoethanolamine soap, wherein oleic acid potassium soap is preferred.
Further preferably, the mass ratio of the ricinoleic acid amide polyoxyethylene ether to the fatty acid salt is 1:5.
preferably, the composition is prepared as follows: 1) Uniformly mixing 1/3 part of ricinoleic acid amide polyoxyethylene ether and fatty acid salt; 2) Adding water with the formula amount into the mixture obtained in the step 1), and stirring until the water is completely dissolved; 3) Adding the rest 2/3 parts of ricinoleic acid amide polyoxyethylene ether into the step 2), and uniformly mixing.
Table 1 shows the compositions of examples 1 to 5
Figure BDA0003540481830000021
Figure BDA0003540481830000031
To further illustrate the effect of the compositions of the present invention on improving the stability of PCMX sterile fluids, and on reducing the co-solvent in the sterile fluids, the effects of the above examples 1-5 on PCMX sterile fluids are exemplified. The high temperature stability test method is that the sample is placed in a 48 ℃ incubator for 30 days, taken out and observed to see whether layering exists. The low temperature stability test method is that the sample is placed in a constant temperature box at 5 ℃ for 30 days, and is taken out to observe whether layering or precipitation exists.
Table 2: examples 1 to 5 apply to a PCMX-containing antibacterial liquid
Figure BDA0003540481830000032
As can be seen from Table 2, the composition of the present invention helps to reduce the amount of solvent used and to improve the high and low temperature stability of the antiseptic solution, as compared to a PCMX antiseptic solution with only castor oil soap.

Claims (9)

1. A composition beneficial to the stability of a PCMX antiseptic solution, characterized by comprising the following components in percentage by mass: 3-6% of ricinoleic acid amide polyoxyethylene ether, 15-30% of fatty acid salt and the balance of water; wherein, the ricinoleic acid amide polyoxyethylene ether comprises the following components in percentage by mass: 15-60% of ricinoleic acid amide polyoxyethylene ether with the addition number of the ethylene oxide being 1-5; 30-80% of ricinoleic acid amide polyoxyethylene ether with the addition number of ethylene oxide being 15-20.
2. The composition of claim 1, wherein the fatty acid salt comprises castor oil soap.
3. The composition according to claim 2, wherein the castor oil soap is present in the fatty acid salt in a mass percentage of 70-100%.
4. A composition according to claim 2 or 3, wherein the fatty acid salt comprises an oleate salt.
5. The composition according to claim 4, wherein the oleate is 0-30% by mass of the fatty acid salt.
6. Composition according to claim 1, characterized in that the mass ratio of ricinoleic acid amide polyoxyethylene ether to fatty acid salt is preferably 1:5.
7. the composition according to claim 1, wherein the composition is prepared by the following method:
1) Uniformly mixing 1/3 part of ricinoleic acid amide polyoxyethylene ether and fatty acid salt;
2) Adding water with the formula amount into the mixture obtained in the step 1), and stirring until the water is completely dissolved;
3) Adding the rest 2/3 parts of ricinoleic acid amide polyoxyethylene ether into the step 2), and uniformly mixing.
8. A PCMX-containing antiseptic solution comprising PCMX, further comprising the composition of any one of claims 1 to 7, wherein the composition comprises 5-18% by mass.
9. The PCMX-containing antiseptic solution of claim 8, wherein the mass ratio of PCMX to the composition is 0.2-0.5:1.
CN202210237496.9A 2022-03-10 2022-03-10 Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX Active CN114586775B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210237496.9A CN114586775B (en) 2022-03-10 2022-03-10 Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210237496.9A CN114586775B (en) 2022-03-10 2022-03-10 Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX

Publications (2)

Publication Number Publication Date
CN114586775A CN114586775A (en) 2022-06-07
CN114586775B true CN114586775B (en) 2023-06-02

Family

ID=81809285

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210237496.9A Active CN114586775B (en) 2022-03-10 2022-03-10 Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX

Country Status (1)

Country Link
CN (1) CN114586775B (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319165D0 (en) * 2003-06-04 2003-09-17 Unilever Plc Improved cleaning composition
CN102464598B (en) * 2010-11-17 2013-12-25 中国石油化工股份有限公司 Fatty acid amide polyoxylethylene ether benzene sulfonate and preparation method thereof
CN103820240A (en) * 2014-02-28 2014-05-28 李克豪 Laundry detergent used for washing underwear
CN106465715A (en) * 2016-09-22 2017-03-01 长兴净安环保科技有限公司 A kind of multi-functional bacteria-removing liquid and preparation method thereof
CN109294760A (en) * 2018-08-04 2019-02-01 山东消博士消毒科技股份有限公司 A kind of formula and preparation method of the clothes washing liquid with fungistatic effect
CN111088012B (en) * 2018-10-23 2022-09-06 中国石油化工股份有限公司 Composite surfactant for improving crude oil recovery efficiency and preparation method and application thereof
WO2020135600A1 (en) * 2018-12-28 2020-07-02 南京善思生物科技有限公司 Nano pesticide formulation and preparation method therefor
IT202000004816A1 (en) * 2020-03-06 2021-09-06 Alpha Biopesticides Ltd PESTICIDE COMPOSITION FOR THE CARE AND PROTECTION OF CROPS
CN113930965B (en) * 2021-11-22 2023-08-25 广州立白企业集团有限公司 Fabric degerming composition
CN114105835B (en) * 2022-01-26 2022-05-06 山东新港化工有限公司 Anionic nonionic gemini surfactant as well as preparation method and application thereof

Also Published As

Publication number Publication date
CN114586775A (en) 2022-06-07

Similar Documents

Publication Publication Date Title
CN106318686B (en) Efficient environment-friendly concentrated hard surface cleaning agent
JP2018095641A (en) Plant-derived disinfection composition, disinfectant and manufacturing method therefor
CN111631217A (en) Low-odor low-corrosivity neutral peroxyacetic acid disinfectant and preparation method thereof
CN112244040B (en) Hydrogen peroxide silver ion composite disinfectant
US20110028546A1 (en) Novel antimicrobial formulations incorporating alkyl esters of fatty acids and nanoemulsions thereof
CN108530691A (en) A kind of degradable biological polysaccharide lotion mulch and preparation method thereof
CN101245288A (en) Table service abluent
CN104365581A (en) Novel specimen conservation solution
CN106190639A (en) A kind of cleaning agent
CN114081031A (en) Low-temperature peracetic acid disinfectant
CN113349201A (en) Ethanol-gel-free no-wash disinfectant and preparation method thereof
CN114586775B (en) Composition beneficial to stability of PCMX (prestressed concrete cylinder pipe) degerming liquid and degerming liquid containing PCMX
CN104770468A (en) Microemulsion containing natamycin
CN111763582B (en) Disinfecting laundry detergent and preparation method thereof
CN110710530B (en) Compound disinfectant composition and disinfection method
CN107502468A (en) A kind of medicine equipment cleaning agent and preparation method thereof
CN103666831A (en) Mobile phone cleaning and disinfection agent having dual effects of cleaning and disinfection
CN113801028B (en) Special surfactant for hydrogen peroxide and compound thereof
CN105191941B (en) Microbicide solution and its application containing sophorolipid
JPWO2004093859A1 (en) Disinfectant composition for dilution
KR100956801B1 (en) Method for manufacturing rust eliminating agent using microbe, and rust eliminating agent made thereby
CN110037050B (en) High-efficiency compound iodine solution and preparation method thereof
CN114557345A (en) Disinfectant and preparation method thereof
CN1190121A (en) Preparation of plant composition detergent
CN107265674A (en) A kind of disinfection purifying and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant